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Introduction
In 2002, a poster alerted the French health authorities to the possibility that the risk of childhood leukaemia might be increased by hepatitis B vaccination 1 . The potential public health implications of such an association provided the rationale for detailed investigation in the context of the Escale national population-based case-control study of the etiology of childhood cancer. Childhood leukaemia is the most common childhood cancer worldwide. In
France, the incidence is 43 cases per million people and per year, equivalent to about 470 new cases diagnosed each year 1 . Very few risk factors, such as high dose ionizing radiation, some chemotherapeutic regimens and some genetic syndromes (Down syndrome, Fanconi syndrome), have been identified. Current research is focusing on infectious, environmental and genetic factors which may influence the risk of childhood leukaemia. Since leukaemia is a neoplastic disease of immune cells, a relationship between immune system events, such as infection, atopic disease or vaccination, and the risk of childhood leukaemia has been suggested. This paper investigates the relationship between vaccination and the risk of the immunologic subtypes of childhood acute leukaemia (AL): acute lymphoblastic leukaemia (ALL) and acute myeloblastic leukaemia (AML).
Methods
The ESCALE study, a national, comprehensive, case-control study conducted in 2003 and 2004, addressed 4 childhood neoplastic diseases (leukaemia, lymphoma, neuroblastoma and brain tumor) and infectious, environmental and genetic potential risk factors.
Study population
Each case of acute leukaemia incident in 2003-2004 in a child aged less than 15 years, residing in France at the time of diagnosis and with no previous history of malignancy was eligible. All the childhood leukaemia cases were confirmed by bone marrow analysis.
Children whose mother did not speak French or who had been adopted were not eligible.
The cases' mothers were interviewed at least 2 months after diagnosis, within 5 months on average. For ethical reasons, the mothers of children who died before the scheduled interview date were not interviewed. 
Statistical analysis
The SAS ® software package (version 8, Cary, North Carolina) was used for all the analyses.
Non-conditional logistic regression was used to estimate odds ratios (OR) and 95%
confidence intervals (CI), with adjustment for age and gender. In order to compare the different types of leukaemia, analyses were carried out using polytomous logistic regression.
Age adjustment for children aged less than 2 years was conducted at intervals of 3 months.
For the other age groups, adjustment complied with the stratification categories.
When the exact day of injection was not reported, a default value of 15 was allocated. When the month was not reported, the date was considered missing. Only 25 case mothers (3.2%), consisting in 18 ALL (2.9%), 5 AML (5.5%) and 2 other types of AL, and 34 control mothers (2.1%) did not manage to have their child's immunization records for the interview.
Pre-diagnosis symptoms of childhood leukaemia such as fever, extreme fatigue or bone pain develop, at the latest, 2 or 3 months before diagnosis. As such symptoms may result in the child's physician postponing a scheduled vaccination, the vaccination data were censored at 6 months before the reference date for cases and controls. Similarly, surgery or disease related to a malformation (38 cases and 56 controls) or genetic abnormality (14 cases and 5 controls) may result in a scheduled vaccination date being modified. In consequence, those 6 cases and controls were excluded from analysis. Thus, out of the 776 cases and 1681 controls who were eligible, 726 cases (3 cases presented with both a malformation and a genetic abnormality) and 1620 controls were included in the analysis. When analyses concerned a given step of the vaccination calendar, only children having reached at least the corresponding age plus 6 months were included, so that both cases and controls could have completed this step. Therefore, analyses made for vaccinations before 6 months and 18 months were carried out among children at least 1 year and 2 years old, respectively.
Results
Among the 726 cases, 620 (85%) presented with acute lymphoblastic leukaemia, 91 (13%) with myeloblastic leukaemia, 11 (2%) with biphenotypic leukaemia and 4 with acute leukaemia with no immunophenotyping at the date of interview.
The cases and controls did not differ with respect to gender or the number of children living in the household (table 1) . There was a small age discrepancy between the cases and controls, particularly for very young children, who were more strongly represented in the control group. The discrepancy simply reflects the fact that the cases were only a fraction of the total case population of the ESCALE study, since only the leukaemia cases are considered herein. There was at least one control for each case in each age group. Cases and controls were similar with respect to age (mean age 6,0 years for controls and 5,6 years for cases), maternal education or degree of urbanization. The paternal educational level was, however, higher for the controls.
About 40% of the mothers reported hepatitis B immunization before pregnancy (301 case and 719 control mothers) while only 25 mothers (6 case and 19 control mothers) reported having had hepatitis B.
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At age 6 months, most of the children had been immunized against tuberculosis, diphtheria, tetanus, polio, pertussis and Hib (Table 2) . About one third of the children had been immunized against hepatitis B and less than 10% against Meningococcus or Pneumococcus.
At age 18 months, most of the children had also been immunized against measles, mumps and rubella (Table 3 ). No association between the number of injections received and the risk of childhood leukaemia was observed (table 4) . The results were the same for ALL alone and for AML alone. There was no association between the total number of vaccine doses received and the risk of acute leukaemia, ALL or AML.
A child aged 6 months should have received at least 4 injections (1 BCG and 3 DTP). An investigation to determine whether an unvaccinated or less-vaccinated status was associated with a risk of childhood leukaemia was therefore conducted. For all types of acute leukaemia taken together, there was no association between the number of injections or doses received before age 6 months and the risk of childhood leukaemia (table 5 
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The controls were randomly selected from the overall population. The national telephone directory was used as the basis for random selection, given that the subpopulation of telephone owners is comparable to the overall population as regards most sociodemographic characteristics and lifestyle. Unlisted numbers were computer generated prior to the random selection in order to avoid selection bias. The cases and controls did not differ with respect to age (considering all types of cancer) or gender. There was no difference between the controls and overall population with regard to birth order [2] [3] [4] , indicating that the quota recruitment process was successful. The controls were representative of the national population in terms of the number of children (0-14) living in the household, which was used as a proxy of birth order, in order to prevent selection bias. Birth order may be, indeed, highly sensitive to the sampling process and may also be related to a number of other variables such as early daycare, early common infections 5 and compliance with the recommended vaccination program 6 . The control mothers' educational level was very similar to that of the French population 2-4 but the control fathers' educational level was higher than that of the overall population. However, the results were unchanged after adjusting for those two variables. A report on childhood vaccinal coverage 7 showed that, in France (1998), 97% of 2-year-old children had been immunized against diphtheria, poliomyelitis and tetanus, 81% against tuberculosis, 82% against measles and rubella, and 96% against mumps compared to 95%, 90%, 88% and 88%, respectively, in the 2-year-old controls . It is therefore likely that vaccination records are also complete. It was difficult to exclude interviewer error in data recording. In order to minimize the risk of error, particularly that associated with the emotional stress of interviewing cases' mothers, the same standardized questionnaire was used for both the cases and controls and each interviewer interviewed both case and control mothers.
The data on vaccinations 6 months prior to the reference date were censored. However, the results remained unchanged when none of those data were censored.
Most of the cases and controls had been immunized against tuberculosis, diphtheria, tetanus, poliomyelitis, pertussis and Hib at the reference date and very few children had never been vaccinated. There were no differences between the cases and controls. The results with regard to immunization prevalence rates and the lack of association with the risk of childhood leukaemia are consistent with those of most studies [9] [10] [11] [12] [13] .
An association between hepatitis B vaccination and the risk of childhood leukaemia has been suggested in a preliminary report from the Northern California Childhood Leukaemia Study 14 . The present study provided no evidence of such an association irrespective of the type of acute leukaemia, age or number of vaccine doses received. These results are consistent with the final results of the Northern California Childhood Leukaemia Study 11 and with the two studies that have investigated hepatitis B vaccination and the risk of acute leukaemia 9, 11 . This study is the first to include the mother's hepatitis B status in the analysis. Maternal hepatitis B status could not, therefore, have constituted a confounding factor.
Several studies have reported an increasing negative association between the number of vaccine or combined-vaccine injections received and the risk of childhood acute leukaemia 9, [11] [12] [13] . Only one study of the relationship between the overall number of injections and the risk of ALL has been published 13 . It showed the same increasing negative association. None of those studies addressed the relationship between the number of doses received and the risk of acute leukaemia other than ALL. In this study, there was no obvious association between the number of injections received or the number of vaccine doses received and the risk of ALL or AML.
Given that a relationship between a low number of early common infections and the risk of acute leukaemia has been suggested in several articles 5, [15] [16] [17] [18] [19] , it was considered pertinent to
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detected. An association was found for AML with fewer injections before the age of 6 months, but it appeared unstable and without any trend as regards the age of injections, suggesting that this association was most probably observed by chance.
Despite the statistical power of the study (80%), no evidence of a relationship between vaccination and the risk of acute lymphoblastic or myeloblastic leukaemia was evidenced irrespective of the type of vaccine, number of doses or number of early vaccinations.
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